ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260233.2	AKT inhibitor VIII	Bladder urothelial carcinoma	0.02281718	Resistant
ENSG00000260233.2	AKT inhibitor VIII	Lymphoid neoplasm diffuse large B-cell lymphoma	0.013224987	Sensitive